446284-44-2 Usage
Molecular Weight
214.51 g/mol The molecular weight is the mass of one mole of the compound, calculated by adding the atomic weights of all the elements in the molecular formula.
Chemical Structure
A pyrrolopyridine ring with bromine and chlorine substituents at the 7th and 4th positions, respectively The chemical structure describes the arrangement of atoms in the compound and the chemical bonds between them.
Heterocyclic Compound
A compound that contains at least one ring structure with atoms of different elements This compound is a heterocyclic compound because it contains a pyrrolopyridine ring with different elements.
Potential Pharmaceutical Applications
The compound has potential applications in the pharmaceutical industry, particularly in the development of new drugs The presence of bromine and chlorine atoms in its structure can impart unique chemical and biological properties, making it a valuable building block for drug discovery and development.
Target for Chemical Synthesis and Study
The structural motifs and properties make it a target for chemical synthesis and study in medicinal chemistry and drug design The compound's unique structure and properties make it a valuable target for further study and development in the field of medicinal chemistry and drug design.
Check Digit Verification of cas no
The CAS Registry Mumber 446284-44-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,8 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 446284-44:
(8*4)+(7*4)+(6*6)+(5*2)+(4*8)+(3*4)+(2*4)+(1*4)=162
162 % 10 = 2
So 446284-44-2 is a valid CAS Registry Number.
446284-44-2Relevant articles and documents
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 79, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.